• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

AABB Issues Updated TRALI Risk Reduction Standards

August 23, 2013

The AABB has issued updated standards for blood banks and transfusion servicesto reduce the risk of transfusion-related acute lung injury (TRALI). The 29th edition of Standards for Blood Banks and Transfusion Services were approved by the AABB Board of Directors in July 2013. This edition includes new requirements for evaluating the eligibility of donors implicated in TRALI events and updated specifications for donors of high plasma volume components used in allogeneic transfusion. Specifically, “high plasma volume components for allogeneic transfusion (i.e. plasma, high plasma volume platelet components, and whole blood) shall be from males, females who have not been pregnant, or females who have been tested since their most recent pregnancy and results interpreted as negative for HLA antibodies.” The new standards will go into effect on April 1, 2014.

 

 

Reference

1.    AABB. TRALI Risk Reduction Requirements in the 29th Edition of BBTS Standards. Accessed onilne August 21, 2013.  2013. http://www.aabb.org/sa/standards/Pages/trali-requirements-bbts-standards.aspx.

Filed Under

  • Adverse Events (non-infectious)
  • News
  • Policy and Guidelines
  • Quality Control and Regulatory

Recommended

  • Matrix-Assisted Laser Deabsorption/Ionization Time of Flight Mass Spectrometry Shows Promise for Blood Group Genotyping

  • American Medical Association Opposes FDA Blood Donation Ban for Gay Men

  • Donor-Specific Antibody Levels and Platelet Transfusion Response Among Refractory Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Ferritin-Guided Donation Policies Decrease Iron Deficiency

  • RBC Transfusions to Treat Acute Heavy Menstrual Bleeding

  • RBC Transfusion Outcomes Similar in ICU Patients with and Without Cardiovascular Disease

  • Cryopreserved vs. Standard Platelets for Surgical Bleeding

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley